CTRI/2020/03/023706暂停未知
Effectiveness of once a week, supervised, outpatients Pulmonary Rehabilitation(PR) in a resource constraint primary care setting over one year- A prospective pre and postinterventional study
Dr Nagesh Dhadge0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 暂停
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients between the age groupof 40-80 years fromboth gender
- •Physician diagnosed chronic respiratory conditions from the above list
- •mMRC(modified Medical Research Council ) dyspnea scale of 1 and more
- •Subjects willing to participate in once a week supervised pulmonary rehabilitation program
排除标准
- •Inability to provide consent for the PR program
- •Recent acute myocardial infarction or cardiac intervention within four weeks
- •Any major surgery within last four weeks
- •Presence of severe arthritis or severe peripheral vascular disease
- •Severe psychiatric or cognitive affection or inability to follow instructions in PR
- •Any other clinical observation in the opinion of treating physician precluding safe PR
研究者
相似试验
终止
4 期
Treatment of clozapine associated obesity and diabetes with exenatide in people with schizophreniaTreatment resistant schizophreniaMetabolic and Endocrine - DiabetesMental Health - SchizophreniaDiet and Nutrition - ObesityobesitydiabetesACTRN12615000524594The University of Queensland28
已完成
不适用
Psychological treatments of post-traumatic stress disorderPost-traumatic stress disorder (PTSD)Mental and Behavioural DisordersStress disordersISRCTN48524925King's College London (UK)120
进行中（未招募）
1 期
Investigation of safety and efficacy of once-daily semaglutide in obese subjects without diabetes mellitusObesityEUCTR2014-001540-38-GBovo Nordisk A/S957
进行中（未招募）
1 期
Investigation of safety and efficacy of once-daily semaglutide in obese subjects without diabetes mellitusMedDRA version: 18.1Level: PTClassification code 10029883Term: ObesitySystem Organ Class: 10027433 - Metabolism and nutrition disordersObesityEUCTR2014-001540-38-BEovo Nordisk A/S935
进行中（未招募）
1 期
Investigation of safety and efficacy of once-daily semaglutide in obese subjects without diabetes mellitusObesityEUCTR2014-001540-38-DEovo Nordisk A/S935